The electronic data capture systems market has seen considerable growth due to a variety of factors.
• In recent times, the market size for electronic data capture systems has seen a swift uptick. The market value will rise from $2.02 billion in 2024 to $2.34 billion in 2025, boasting a compound annual growth rate (CAGR) of 16.1%.
Factors such as regulatory compliance, initiatives for cost reduction, increased complexity in clinical trials, the requirement for immediate data access, and internationalization of clinical trials account for the growth observed in the historical period.
The electronic data capture systems market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for electronic data capture systems is predicted to experience substantial growth in the coming years. It is projected to expand to $4.21 billion in 2029, with a compound annual growth rate (CAGR) of 15.7%.
The prospective growth can be linked to various factors such as an aging population and chronic diseases, the rise of personalized medicine and precision healthcare, the adoption of risk-based monitoring, and the extension of real-world evidence (RWE) studies and burgeoning markets. Key trends that will shape the market in the forecast period encompass heightened attention to patient-centricity, the incorporation of artificial intelligence and machine learning, the proliferation of decentralized clinical trials, the rise of wearable technology integration, and a stronger emphasis on data security and privacy.
The electronic data capture systems market is anticipated to expand due to the increasing need for outsourcing clinical trials to contract research organizations. Outsourcing clinical trials implies handing over various elements of these trials to external bodies or service providers on behalf of pharmaceutical, biotechnology, or medical device corporations. This need for outsourcing is fueled by numerous benefits offered by contract research organizations (CROs) including cost effectiveness, expertise accessibility, worldwide reach, adaptability, scalability, and a concentration on core skills. Electronic data capture systems, facilitating digital collection, management and analysis of patient data, are employed within clinical trials to streamline data collection, escalate accuracy and promote real-time trial outcome monitoring and reporting. For instance, Applied Clinical Trials Online, an MJH Life Sciences-owned digital platform, reported in October 2023 that large biopharma companies' functional service provider (FSP) outsourcing usage is witnessing over 13% annual growth. Consequently, the growing need for clinical trials' outsourcing to clinical research organizations is contributing to the expansion of the electronic data capture systems market.
The electronic data capture systems market covered in this report is segmented –
1) By Component: Software, Services
2) By Clinical Trial Phase: Phase I, Phase II, Phase III, Phase IV
3) By Delivery Mode: Cloud-Based (SAAS) Solutions, Web-Hosted (On-Demand) Solutions, Licensed Enterprise (On-Premise) Solutions
4) By End-User: Hospitals Or Healthcare providers, Contract Research Organizations, Pharmaceutical And Biotechnology Firms, Medical Device Firms, Other End-Users
Subsegments:
1) By Software: EDC Software Platforms, Cloud-Based EDC Software, Mobile EDC Software
2) By Services: Implementation Services, Consulting Services, Support And Maintenance Services, Training Services
Leading organizations in the electronic data capture systems market are emphasizing the creation of ground-breaking software solutions, such as electronic data capture (EDC) platforms for clinical studies. An EDC platform for clinical studies is a digital instrument designed to efficiently collect and control trial data, guaranteeing data precision, real-time access, and compliance with regulations. For example, Cloudbyz, an American cloud tech firm, launched Cloudbyz EDC 2.0 in March 2023. This advanced Electronic Data Capture platform is designed to boost clinical research processes. The platform improves operational efficiency, safeguards data integrity, aids regulatory compliance, and hastens the distribution of novel treatments to patients. Cloudbyz EDC 2.0 simplifies the collection and management of data, decreases manual mistakes, and complies with global regulatory norms, such as FDA 21 CFR Part 11 and GDPR.
Major companies operating in the electronic data capture systems market report are:
• International Business Machines Corporation (IBM)
• Oracle Corporation
• IQVIA Inc.
• Parexel International Corporation
• Veeva Systems Inc.
• Clario Medical Imaging
• Medidata Solutions Inc.
• Signant Health
• Calyx International
• ArisGlobal LLC
• Kinapse Ltd.
• Merge Healthcare Inc.
• OmniComm Systems Inc.
• MedNet Solutions
• eClinical Solutions
• BioForum Group
• Acceliant Corporation
• DATATRAK International Inc.
• OpenClinica LLC
• Castor EDC
• DatStat Inc.
• eResearchTechnology Inc.
• Cmed Technology Ltd.
• Clinerion Ltd.
• Arithmos Srl.
North America was the largest region in the electronic data capture systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the electronic data capture systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.